NextCure, Inc.
NXTC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $13,109 | $13,443 | $21,588 |
| - Cash | $7,324 | $4,892 | $21,827 | $27,727 |
| + Debt | $4,411 | $4,666 | $5,842 | $5,949 |
| Enterprise Value | – | $12,883 | -$2,542 | -$190 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,091 | -$26,659 | -$10,968 | -$11,781 |
| % Margin | – | – | – | – |
| Net Income | -$8,624 | -$26,808 | -$10,976 | -$11,603 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.22 | -11.29 | -4.703 | -4.972 |
| % Growth | 71.5% | -140.1% | 5.4% | – |
| Operating Cash Flow | -$6,268 | -$22,713 | -$12,994 | -$6,969 |
| Capital Expenditures | $0 | $0 | $0 | $34 |
| Free Cash Flow | -$6,268 | -$22,713 | -$12,994 | -$6,935 |